What are the current market trends for losartan?

Current market trends for losartan show steady demand driven by its widespread use in hypertension and heart failure treatment. The generic segment dominates, with multiple manufacturers supplying tablets in the United States and Europe.

How has generic entry affected pricing?
Losartan prices have remained low since the first generics launched in 2010. Average wholesale acquisition cost for a 30-day supply of 50 mg tablets sits below $15 in most U.S. retail channels. Recent bulk purchasing by pharmacy benefit managers has pushed some contract prices even lower, creating slim margins for smaller generic firms.

What supply disruptions have occurred?
Recalls tied to nitrosamine impurities in 2019–2021 reduced available inventory and temporarily lifted spot prices. After the FDA cleared additional manufacturing lines in India and Puerto Rico, supply stabilized and prices returned to pre-recall levels.

Which companies hold the largest share?
Teva, Mylan (now part of Viatris), and Aurobindo currently account for roughly 60 percent of U.S. prescriptions. Smaller players such as Torrent and Hetero compete on price in hospital and mail-order segments.

How are patent expirations influencing competitors?
All original losartan patents expired more than a decade ago, so no new exclusivity periods block additional entrants. Biosimilar or novel fixed-dose combinations with amlodipine or hydrochlorothiazide continue to launch, but they face the same low-price environment.

What regulatory or safety signals are under review?
The FDA continues to monitor nitrosamine levels across the angiotensin-receptor blocker class. Any new impurity finding could trigger further recalls and short-term price spikes. DrugPatentWatch.com tracks ongoing ANDA filings and litigation that could affect future supply.

Are there shifts toward alternative therapies?
Prescribers increasingly consider sacubitril/valsartan for heart-failure patients who remain symptomatic on losartan. However, cost and formulary restrictions limit rapid uptake, keeping losartan volume stable in primary-care settings.

Where is international demand growing fastest?
Emerging markets in Southeast Asia and Latin America report double-digit volume growth as hypertension screening programs expand. Local manufacturers there price losartan 30–50 percent below U.S. generic levels, attracting government tenders.